WO2004067569A8 - Internalising human binding molecules against cd72 - Google Patents
Internalising human binding molecules against cd72Info
- Publication number
- WO2004067569A8 WO2004067569A8 PCT/EP2003/050004 EP0350004W WO2004067569A8 WO 2004067569 A8 WO2004067569 A8 WO 2004067569A8 EP 0350004 W EP0350004 W EP 0350004W WO 2004067569 A8 WO2004067569 A8 WO 2004067569A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- internalising
- human binding
- binding molecules
- molecules against
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention provides internalising human binding molecules that specifically bind to CD72, nucleic acid molecules encoding the internalising human binding molecules, compositions comprising the internalising human binding molecules and methods of identifying or producing the internalising human binding molecules. In a preferred aspect, the invention provides immunoconjugates comprising an internalising human binding molecules that specifically binds to CD72. The internalising human binding molecules and immunoconjugates comprising an internalising human binding molecule can be used in the diagnosis and treatment of B cell associated disorders.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2003209753A AU2003209753A1 (en) | 2003-01-27 | 2003-01-27 | Internalising human binding molecules against cd72 |
| PCT/EP2003/050004 WO2004067569A1 (en) | 2003-01-27 | 2003-01-27 | Internalising human binding molecules against cd72 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2003/050004 WO2004067569A1 (en) | 2003-01-27 | 2003-01-27 | Internalising human binding molecules against cd72 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2004067569A1 WO2004067569A1 (en) | 2004-08-12 |
| WO2004067569A8 true WO2004067569A8 (en) | 2005-03-17 |
Family
ID=32798703
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/EP2003/050004 Ceased WO2004067569A1 (en) | 2003-01-27 | 2003-01-27 | Internalising human binding molecules against cd72 |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2003209753A1 (en) |
| WO (1) | WO2004067569A1 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004003144A2 (en) | 2002-07-01 | 2004-01-08 | Human Genome Sciences, Inc. | Antibodies that specifically bind to reg iv |
| AU2004251890B2 (en) * | 2003-06-25 | 2010-09-23 | Crucell Holland B.V. | Binding molecules for the treatment of myeloid cell malignancies |
| US8877199B2 (en) * | 2009-05-15 | 2014-11-04 | The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services | B cell surface reactive antibodies |
| EP2997944B1 (en) * | 2014-09-19 | 2018-01-10 | Permobil AB | Chassis arrangement for an electrically powered wheelchair and an electrically powered wheelchair comprising the same |
| US11708423B2 (en) | 2017-09-26 | 2023-07-25 | Cero Therapeutics, Inc. | Chimeric engulfment receptor molecules and methods of use |
| US12303551B2 (en) | 2018-03-28 | 2025-05-20 | Cero Therapeutics Holdings, Inc. | Cellular immunotherapy compositions and uses thereof |
| WO2022036287A1 (en) * | 2020-08-14 | 2022-02-17 | Cero Therapeutics, Inc. | Anti-cd72 chimeric receptors and uses thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA01011279A (en) * | 1999-05-07 | 2002-07-02 | Genentech Inc | Treatment of autoimmune diseases with antagonists which bind to b cell surface markers. |
-
2003
- 2003-01-27 AU AU2003209753A patent/AU2003209753A1/en not_active Abandoned
- 2003-01-27 WO PCT/EP2003/050004 patent/WO2004067569A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003209753A1 (en) | 2004-08-23 |
| WO2004067569A1 (en) | 2004-08-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2005063819A3 (en) | Human binding molecule against cd1a | |
| WO2005118644A3 (en) | Binding molecules capable of neutralizing rabies virus and uses thereof | |
| WO2005012360A3 (en) | Binding molecules against sars-coronavirus and uses thereof | |
| WO2004106380A3 (en) | Human-anti-human cd3 binding molecules | |
| WO2005014035A3 (en) | Use of galactose oxidase for selective chemical conjugation of protractor molecules to proteins of therapeutic interest | |
| WO2010077422A3 (en) | Formulations of single domain antigen binding molecules | |
| WO2011020783A3 (en) | Targeted immunoconjugates | |
| WO2005017205A3 (en) | Nucleic acid mapping using linear analysis | |
| WO2007141274A3 (en) | Human binding molecules having killing activity against staphylococci and uses thereof | |
| WO2007092640A3 (en) | Antibodies that bind par-2 | |
| WO2008151819A3 (en) | Treatment of tumors using specific anti-l1 antibody | |
| WO2007067730A3 (en) | Human monoclonal antibodies to protein tyrosine kinase 7 ( ptk7 ) and their use | |
| WO2006040129A3 (en) | Ubiquitin or gamma-crystalline conjugates for use in therapy, diagnosis and chromatography | |
| WO2007002223A3 (en) | Cd19 antibodies and their uses | |
| IL188113A (en) | Nucleic acid constructs encoding a cross-reactive analogue of psma288-297 and prame425-433, or cross-reactive analogue thereof and use thereof in the preparation of medicaments for treating cancer | |
| WO2007067991A3 (en) | Human monoclonal antibodies to o8e | |
| WO2008136848A3 (en) | Novel anti-notch3 antibodies and their use in the detection and diagnosis of disease | |
| WO2006076691A8 (en) | Irta-2 antibodies and their uses | |
| WO2008080091A3 (en) | Activation of rig-i pathway | |
| WO2007134350A3 (en) | Antibodies specific for bet v 1 and use thereof in the prevention and treatment of bet v 1-induced diseases | |
| WO2004067569A8 (en) | Internalising human binding molecules against cd72 | |
| WO2003102185A3 (en) | Methods and compositions for treating neoplasia relating to hnrnp a1 and a2 nucleic acid molecules | |
| WO2007034042A3 (en) | Vanilla planifolia extract, method for obtaining same, and cosmetic or dermatological composition containing same | |
| WO2006122971A3 (en) | Treatment of disease using an improved regulated expression system | |
| WO2004074436A3 (en) | Methods of use of a gpcr in the diagnosis and treatment of colon and lung cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| CFP | Corrected version of a pamphlet front page | ||
| CR1 | Correction of entry in section i |
Free format text: IN PCT GAZETTE 33/2004 ADD "DECLARATION UNDER RULE 4.17: - AS TO APPLICANT S ENTITLEMENT TO APPLY FOR AND BE GRANTED A PATENT (RULE 4.17(II))."; ADD "DECLARATION UNDER RULE 4.17: - OF INVENTORSHIP (RULE 4.17(IV)) FOR US ONLY." |
|
| 122 | Ep: pct application non-entry in european phase | ||
| NENP | Non-entry into the national phase in: |
Ref country code: JP |
|
| WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |